Rhythm Pharmaceuticals stock price target raised to $95 by BofA on positive trial data

Related
Ørsted secures $3 billion financing for Greater Changhua 2 o...
14 minutes ago
0
TSMC revenue climbs 39% in latest sign of AI spending boom
17 minutes ago
0
Ford recalls over 850,000 vehicles in US due to fuel pump de...
21 minutes ago
0
OpenAI to launch AI-powered browser, potential challenge to ...
51 minutes ago
0
Chinese property stocks soar on hopes of unverified high-lev...
58 minutes ago
0
ASE Technology’s Q2 revenue climbs 11.2% Y/Y
1 hour ago
0
Germany's inflation drops to 2% in June
2 hours ago
0
PJX Resources launches $1.6M units offering
3 hours ago
0
Japan PPI growth hits 10-month low to 2.9% y/y in June
3 hours ago
0